Alzamend Neuro (ALZN) Long-Term Deferred Tax (2021 - 2022)

Alzamend Neuro has disclosed Long-Term Deferred Tax across 2 years of filings, most recently posting $10.1 million for Q2 2022.

• In Q2 2022, Long-Term Deferred Tax rose 131.9% year-over-year to $10.1 million; the TTM figure through Apr 2022 stood at $10.1 million (up 131.9% YoY), while the FY2022 annual figure was $10.1 million, up 131.9% from the prior year.
• Long-Term Deferred Tax came in at $10.1 million for Q2 2022 at Alzamend Neuro, up from $4.4 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $10.1 million in Q2 2022 to a low of $4.4 million in Q2 2021.